<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 07/05/2024</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 07/05/2024</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Mr. Ricardo Fraser</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">December 28, 1946 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Black or African American</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>11237 SW 167TH ST<br/>MIAMI, FL 33157-2713, US<br/><br/>Primary Home Phone:  305-905-9701<br/>Email:  rbfras@yahoo.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">283254 2.16.840.1.113883.4.391.322720<br/>49321 2.16.840.1.113883.4.391.322720.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">eee64dba-ba05-443a-92ff-ace4a60abe98 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">October 7, 2024, 12:56:33 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Wentworth Jarrett</td></tr><tr><td class="td_header_role_value internal_format">12955 SW 132ND ST<br/>STE 104<br/>MIAMI, FL 33186-6224, US<br/><br/>Tel:  305-520-5750<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">5741745 2.16.840.1.113883.4.391.322720</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From July 5, 2024, 10:00:00   to July 5, 2024, 10:30:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.322720</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Wentworth Jarrett</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">12955 SW 132ND ST<br/>STE 104<br/>MIAMI, FL 33186-6224, US<br/><br/>Tel:  305-520-5750<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">Ricardo Fraser<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  305-905-9701<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Wentworth Jarrett signed at July 5, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">12955 SW 132ND ST<br/>STE 104<br/>MIAMI, FL 33186-6224, US<br/><br/>Tel:  305-520-5750<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">Dr Wentworth Jarrett PA</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">12955 SW 132ND ST<br/>STE 104<br/>MIAMI, FL 33186-6224, US<br/><br/>Tel:  305-520-5750<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Problems</a></li><li><a href="#id6">Vital Signs</a></li><li><a href="#id7">Encounters</a></li><li><a href="#id8">Assessments</a></li><li><a href="#id9">Plan Of Treatment</a></li><li><a href="#id10">Progress Notes</a></li><li><a href="#id11">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>Patient presents to office HTN, cholesterol, medication and bloodwork follow up</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Losartan Potassium-HCTZ 100-25 MG</td><td ID="instruction1">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Atorvastatin Calcium 10 MG</td><td ID="instruction2">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Pantoprazole Sodium 40 MG</td><td ID="instruction3"> Oral for 30 Days</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication4">dilTIAZem HCl ER Coated Beads 120 MG</td><td ID="instruction4">TAKE 1 CAPSULE BY MOUTH EVERY DAY</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication5">Dabigatran Etexilate Mesylate 150 MG</td><td ID="instruction5">1 capsule Orally Twice a day for 90 days</td><td ID="medication5notes">Stop xarelto ,Change to Pradaxa generic</td><td/><td/><td>Active</td></tr><tr><td ID="medication6">Pantoprazole Sodium 40 MG</td><td ID="instruction6">1 tablet Orally Once a day for 90 days</td><td/><td>07/05/2024</td><td/><td>Active</td></tr><tr><td ID="medication7">Sotalol HCl 80 MG</td><td ID="instruction7">TAKE 1 TABLET BY MOUTH TWICE A DAY Oral for 90 Days</td><td/><td/><td/><td>Not-Taking</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table><span class="content_span">Tobacco Use/Smoking</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Additional Findings: Tobacco Non-User</td><td>Current non-smoker</td><td/></tr></tbody></table><span class="content_span">Alcohol Screen (Audit-C)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>Yes</td><td/></tr><tr><td>How often did you have a drink containing alcohol in the past year?</td><td>Monthly or less (1 point)</td><td/></tr><tr><td>How many drinks did you have on a typical day when you were drinking in the past year?</td><td>1 or 2 drinks (0 point)</td><td/></tr><tr><td>How often did you have 6 or more drinks on one occasion in the past year?</td><td>Never (0 point)</td><td/></tr><tr><td>Points</td><td>1</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody></table></div><h3><a name="id5" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>Essential hypertension (59621000)</td><td ID="Problem1">Essential (primary) hypertension (I10)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Gastroesophageal reflux disease (235595009)</td><td ID="Problem2">GERD (gastroesophageal reflux disease) (K21.9)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>98.1 degrees Fahrenheit</td><td>07/05/2024</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td>133 mm Hg</td><td>07/05/2024</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>79 mm Hg</td><td>07/05/2024</td></tr><tr><th ID="vital4">Heart Rate</th><td>76 /min</td><td>07/05/2024</td></tr><tr><th ID="vital5">Respiratory Rate</th><td>16 /min</td><td>07/05/2024</td></tr><tr><th ID="vital6">Height</th><td>67 in</td><td>07/05/2024</td></tr><tr><th ID="vital7">Weight</th><td>161 lbs</td><td>07/05/2024</td></tr><tr><th ID="vital8">BMI</th><td>25.21 kg/m2</td><td>07/05/2024</td></tr><tr><th ID="vital9">Oximetry</th><td>98 %</td><td>07/05/2024</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>Dr Wentworth Jarrett PA</td><td>12955 SW 132ND ST STE 104 MIAMI, FL 33186-6224</td><td>07/05/2024</td><td>Wentworth Jarrett</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Paroxysmal atrial fibrillation I48.0 ; Prediabetes R73.03 ; Gout, unspecified M10.9 ; Solitary pulmonary nodule R91.1 ; Essential (primary) hypertension I10 ; History of partial nephrectomy Z90.5 ; Pulmonary fibrosis, unspecified J84.10 ; History of kidney cancer Z85.528 ; Hyperlipidemia E78.5 ; Chronic kidney disease, stage 3a N18.31 ; Secondary hypercoagulable state D68.69 and GERD (gastroesophageal reflux disease) K21.9</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">07/05/2024</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td/><td/><td/></tr><tr><td ID="ref2">07/05/2024</td><td>Paroxysmal atrial fibrillation (ICD-10 - I48.0)</td><td/><td/><td/></tr><tr><td ID="ref3">07/05/2024</td><td>Prediabetes (ICD-10 - R73.03)</td><td/><td/><td><p>According to ADA guidelines HA1C% as a criteria of Normal range, Prediabetes and Diabetes criteria:</p><p> </p><p>&lt;5.7%-Normal(Non-diabetic), </p><p> </p><p>5.7-6.4%-Increased risk of diabetes(Prediabetes)</p><p>,  </p><p>&gt;= 6.5%-Consistent with Diabetes.</p><p> Since HA1C is consistent with Prediabetes. Patient has been recommended low carbohydrate diet, increase physical activity, routine labs and follow up advised. Patient has been advised about risks of becoming a diabetic patient.</p></td></tr><tr><td ID="ref4">07/05/2024</td><td>Gout, unspecified (ICD-10 - M10.9)</td><td/><td/><td>Gout symptoms and treatment were discussed with the patient.  I also discussed that weight loss can help relieve gout.  I discussed changes in the diet that may help prevent future gouty attacks including decreasing red meat and seafood as a possibility.  Decreasing alcohol like beer, wine and hard alcohol was recommended..  Decrease the consumption high fructose corn syrup.  I will be notified of any future possible gouty attacks.</td></tr><tr><td ID="ref5">07/05/2024</td><td>Solitary pulmonary nodule (ICD-10 - R91.1)</td><td/><td>Monitoring</td><td/></tr><tr><td ID="ref6">07/05/2024</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td/><td>Reviewed DASH diet &amp; advised at least 30 minutes of exercise 6 days a week.  Monitor  blood pressure periodically.  Aware of goals and risk modifications.</td></tr><tr><td ID="ref7">07/05/2024</td><td>History of partial nephrectomy (ICD-10 - Z90.5)</td><td/><td>Controled with medication</td><td/></tr><tr><td ID="ref8">07/05/2024</td><td>Pulmonary fibrosis, unspecified (ICD-10 - J84.10)</td><td>Calcified Granuloma CXR 04/01/2019</td><td/><td>Instructed patient in pulmonary fibrosis and in how it harms the tissues deep in the lungs. The air sacs in the lungs and their supporting structures become inflamed and scarred. If scarring progresses happen, then it makes your lungs thick and stiff. That makes it hard for the patient to catch their breath, and their blood may not get enough oxygen.</td></tr><tr><td ID="ref9">07/05/2024</td><td>History of kidney cancer (ICD-10 - Z85.528)</td><td/><td>monitor</td><td/></tr><tr><td ID="ref10">07/05/2024</td><td>Hyperlipidemia (ICD-10 - E78.5)</td><td/><td/><td/></tr><tr><td ID="ref11">07/05/2024</td><td>Chronic kidney disease, stage 3a (ICD-10 - N18.31)</td><td/><td>Patient advised on proper diet.  Advised daily exercise and to avoid dehydration, smoking, alcohol and illegal drugs.  Made aware that should avoid substances that are toxic to the kidneys such as nonsteroidal anti-inflammatory drugs.</td><td/></tr><tr><td ID="ref12">07/05/2024</td><td>Secondary hypercoagulable state (ICD-10 - D68.69)</td><td/><td/><td>Patient aware of side effects of anticoagulation understands to report any significant signs of toxicity, bleeding, ecchymosis etc.  Reviewed importance of compliance with continuous monitoring.</td></tr><tr><td ID="ref13">07/05/2024</td><td>GERD (gastroesophageal reflux disease) (ICD-10 - K21.9)</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Losartan Potassium-HCTZ 100-25 MG</td><td>1 tablet Orally Once a day</td><td/><td/><td/></tr><tr><td ID="potMeds2">Atorvastatin Calcium 10 MG</td><td>1 tablet Orally Once a day</td><td/><td/><td/></tr><tr><td ID="potMeds3">Dabigatran Etexilate Mesylate 150 MG</td><td>1 capsule Orally Twice a day for 90 days</td><td/><td/><td>Stop xarelto ,Change to Pradaxa generic</td></tr><tr><td ID="potMeds4">Pantoprazole Sodium 40 MG</td><td>1 tablet Orally Once a day for 90 days</td><td>07/05/2024</td><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Solitary pulmonary nodule</td><td>Monitoring</td></tr><tr><td ID="instructionpot2">History of partial nephrectomy</td><td>Controled with medication</td></tr><tr><td ID="instructionpot3">History of kidney cancer</td><td>monitor</td></tr><tr><td ID="instructionpot4">Chronic kidney disease, stage 3a</td><td>Patient advised on proper diet.  Advised daily exercise and to avoid dehydration, smoking, alcohol and illegal drugs.  Made aware that should avoid substances that are toxic to the kidneys such as nonsteroidal anti-inflammatory drugs.</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 4 Months,prn, Reason: </td></tr><tr><td ID="futureAppt1">Provider Name:Wentworth G Jarrett, 11/08/2024 10:00:00 AM, 12955 SW 132ND ST, STE 104, MIAMI, FL, 33186-6224, 305-520-5750</td></tr></tbody></table></div><h3><a name="id10" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>FRASER, Ricardo <span class="bold">DOB:</span> 12/28/1946 (77 yo M) <span class="bold">Acc No.</span> 49321 <span class="bold">DOS:</span> 07/05/2024</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Notes</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>FRASER, Ricardo<br/><span class="bold">Account Number: </span>49321</td><td align="right"><span class="bold">Provider: </span>Wentworth G. Jarrett, MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>12/28/1946<span class="bold">   Age: </span>77 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>07/05/2024</td></tr><tr><td><span class="bold">Phone: </span>305-905-9701</td></tr><tr><td colspan="2"><span class="bold">Address: </span>11237 SW 167TH ST, MIAMI, FL-33157-2713</td></tr><tr><td colspan="2"><span class="bold">Structured Data: </span> Immunization Data Protection : No</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   1. Patient presents to office HTN, cholesterol, medication and bloodwork follow up. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Constitutional</span>: <br/>       Doing well ~feeling good~Some esophageal symptoms `after eating spicy food.<br/>      Denies : Anorexia. <br/>      Denies : Fatigue. <br/>      Denies : Fever. <br/>      Denies : Joint pains. <br/>      Denies : Myalgia. <br/>      Denies : Neck pain. <br/>      Denies : Night sweats. <br/>      Denies : Weight gain. <br/>      Denies : Weight loss. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General/Constitutional</span>: <br/>      Patient denies falling. Mood Change Denies. Denies Change in appetite. Denies Chills. Denies Fatigue. Denies Fever. Denies Headache. Denies Lightheadedness. Denies Night sweats. Denies Sleep disturbance. Denies Weight gain. Denies Weight loss.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> Atrial fibrillation, Solitary pulmonary nodule, Chronic kidney disease, Stage III (moderate), Pityriasis versicolor, Hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage I through stage IV, or unspecified, Overweight (BMI 25.0-29.9), Other male erectile dysfunction, ATYPICAL ATRIAL FLUTTER, COLONOSCOPY - 06/02/23 - JACKSON SOUTH ADMITTED FOR RECTAL BLEEDING, FLU VACCINE 11/26/2018 (needed), LDL - 11/01/23 - 86, HbA1C - 11/01/23 - 6.1, COA- 05/15/2024, PHQ-9- 04/26/2023.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> ablation of heart 10/2014, partial nephrectomy 04/2019, Ablation of heart and insertion of a looper - Dr, Pascual 08/10/23. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> partial nephrectomy 04/2019, syncope 04/07/2024. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father: deceased, liver failure. Mother: deceased,  diagnosed with Other specified conditions influencing health status. 3 brother(s) , 1 sister(s) . 2 son(s) . . <br/>eldest brother deceased parkinsons\\\\\\\/trouble swallowing\\\\n1 son deceased accidental drowning.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Tobacco Use:</span> <br/>       Tobacco Use/Smoking <br/>         Additional Findings: Tobacco Non-User <span class="italics">Current non-smoker</span><br/>   <span class="Underline">Drugs/Alcohol/Caffeine:</span> <br/>       Drugs <br/>         Have you used drugs other than those for medical reasons in the past 12 months? <span class="italics">No</span><br/>      Alcohol Screen (Audit-C) <br/>         Did you have a drink containing alcohol in the past year? <span class="italics">Yes</span><br/>         How often did you have a drink containing alcohol in the past year? <span class="italics">Monthly or less (1 point)</span><br/>         How many drinks did you have on a typical day when you were drinking in the past year? <span class="italics">1 or 2 drinks (0 point)</span><br/>         How often did you have 6 or more drinks on one occasion in the past year? <span class="italics">Never (0 point)</span><br/>         Points <span class="italics">1</span><br/>         Interpretation <span class="italics">Negative</span><br/>      Alcohol: Occasional - 1 glass of wine. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> Taking Losartan Potassium-HCTZ 100-25 MG Tablet 1 tablet Orally Once a day , Taking Atorvastatin Calcium 10 MG Tablet 1 tablet Orally Once a day , Taking Dabigatran Etexilate Mesylate 150 MG Capsule 1 capsule Orally Twice a day , Notes to Pharmacist: Stop xarelto ,Change to Pradaxa generic, Not-Taking Sotalol HCl 80 MG Tablet TAKE 1 TABLET BY MOUTH TWICE A DAY Oral  , Not-Taking Pantoprazole Sodium 40 MG Tablet Delayed Release  Oral  , Not-Taking dilTIAZem HCl ER Coated Beads 120 MG Capsule Extended Release 24 Hour TAKE 1 CAPSULE BY MOUTH EVERY DAY   , Discontinued Metoprolol Succinate ER 25 mg tablet extended release 24 hour Take 1 tablet(s) by mouth daily Orally Once a day , Discontinued Amiodarone HCl 200 MG Tablet 2 tablets Orally for 7 days , Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Temp: 98.1, HR: 76, BP: 133/79, Ht: 67, Wt: 161, BMI: 25.21, RR: 16, Oxygen sat %: 98.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">Constitutional:</span><br/>      GENERAL APPEARANCE: in no acute distress,  well developed, well nourished. <br/>      HEAD: normocephalic,  atraumatic. <br/>      EYES: pupils equal, round, reactive to light and accommodation. <br/>      EARS: normal. <br/>      ORAL CAVITY: mucosa moist. <br/>      THROAT: clear. <br/>      NECK/THYROID: neck supple, full range of motion,  no cervical lymphadenopathy. <br/>      CHEST clear to auscultation and percussion. Loop felt left chest wall. <br/>      HEART: regular rate and rhythm,  S1, S2 normal,  no murmurs. <br/>      LUNGS: clear to auscultation bilaterally. <br/>      ABDOMEN: normal,  bowel sounds present,  soft, nontender, nondistended. <br/>      EXTREMITIES: no clubbing, cyanosis, or edema. <br/>      NEUROLOGIC: nonfocal,  motor strength normal upper and lower extremities,  sensory exam intact. <br/>      PSYCH: alert, oriented. <br/>      SKIN: no suspicious lesions,  warm and dry.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Paroxysmal atrial fibrillation - I48.0 (Primary) 2. Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease - I12.9 3. Prediabetes - R73.03 4. Gout, unspecified - M10.9 5. Solitary pulmonary nodule - R91.1 6. Essential (primary) hypertension - I10 7. History of partial nephrectomy - Z90.5 8. Pulmonary fibrosis, unspecified - J84.10, Calcified Granuloma CXR 04/01/2019 9. History of kidney cancer - Z85.528 10. Hyperlipidemia - E78.5 11. Chronic kidney disease, stage 3a - N18.31 12. Secondary hypercoagulable state - D68.69 13. GERD (gastroesophageal reflux disease) - K21.9 </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Paroxysmal atrial fibrillation</span> <br/>Continue Dabigatran Etexilate Mesylate Capsule, 150 MG, 1 capsule, Orally, Twice a day, 90 days, 180 Capsule, Refills 3, Notes to Pharmacist: Stop xarelto ,Change to Pradaxa generic.  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</span> <br/>Continue Losartan Potassium-HCTZ Tablet, 100-25 MG, 1 tablet, Orally, Once a day.  </td></tr><tr><td/></tr><tr><td><span class="bold">3. Prediabetes</span> <br/>Clinical Notes: According to ADA guidelines HA1C% as a criteria of Normal range, Prediabetes and Diabetes criteria:<br/> <br/>&lt;5.7%-Normal(Non-diabetic), <br/> <br/>5.7-6.4%-Increased risk of diabetes(Prediabetes)<br/>,  <br/>&gt;= 6.5%-Consistent with Diabetes.<br/><br/> Since HA1C is consistent with Prediabetes. Patient has been recommended low carbohydrate diet, increase physical activity, routine labs and follow up advised. Patient has been advised about risks of becoming a diabetic patient.  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Gout, unspecified</span> <br/>Clinical Notes: Gout symptoms and treatment were discussed with the patient.  I also discussed that weight loss can help relieve gout.  I discussed changes in the diet that may help prevent future gouty attacks including decreasing red meat and seafood as a possibility.  Decreasing alcohol like beer, wine and hard alcohol was recommended..  Decrease the consumption high fructose corn syrup.  I will be notified of any future possible gouty attacks.  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Solitary pulmonary nodule</span> <br/>Notes: Monitoring  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Essential (primary) hypertension</span> <br/>Clinical Notes: Reviewed DASH diet &amp; advised at least 30 minutes of exercise 6 days a week.  Monitor  blood pressure periodically.  Aware of goals and risk modifications.  </td></tr><tr><td/></tr><tr><td><span class="bold">7. History of partial nephrectomy</span> <br/>Notes: Controled with medication  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Pulmonary fibrosis, unspecified</span> <br/>Clinical Notes: Instructed patient in pulmonary fibrosis and in how it harms the tissues deep in the lungs. The air sacs in the lungs and their supporting structures become inflamed and scarred. If scarring progresses happen, then it makes your lungs thick and stiff. That makes it hard for the patient to catch their breath, and their blood may not get enough oxygen.  </td></tr><tr><td/></tr><tr><td><span class="bold">9. History of kidney cancer</span> <br/>Notes: monitor  </td></tr><tr><td/></tr><tr><td><span class="bold">10. Hyperlipidemia</span> <br/>Continue Atorvastatin Calcium Tablet, 10 MG, 1 tablet, Orally, Once a day.  </td></tr><tr><td/></tr><tr><td><span class="bold">11. Chronic kidney disease, stage 3a</span> <br/>Notes: Patient advised on proper diet.  Advised daily exercise and to avoid dehydration, smoking, alcohol and illegal drugs.  Made aware that should avoid substances that are toxic to the kidneys such as nonsteroidal anti-inflammatory drugs.  </td></tr><tr><td/></tr><tr><td><span class="bold">12. Secondary hypercoagulable state</span> <br/>Clinical Notes: Patient aware of side effects of anticoagulation understands to report any significant signs of toxicity, bleeding, ecchymosis etc.  Reviewed importance of compliance with continuous monitoring.  </td></tr><tr><td/></tr><tr><td><span class="bold">13. GERD (gastroesophageal reflux disease)</span> <br/>Start Pantoprazole Sodium Tablet Delayed Release, 40 MG, 1 tablet, Orally, Once a day, 90 days, 90 Tablet, Refills 1.  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Preventive Medicine:</span> <br/>  *QUALITY MEASURES: <br/>       Colorectal Cancer Screening: <br/>          Colonoscopy? <span class="italics">Yes</span><br/>          Date: <span class="italics">06-2023</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 4 Months,prn</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 OFFICEOUTPATIENT VISIT, EST Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> </td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by Wentworth Jarrett , MD  on 07/09/2024 at 12:41 PM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> Wentworth G. Jarrett, MD</td><td align="right"><span class="bold">Date: </span>07/05/2024</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: 10/07/2024 12:56 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id11" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="9">Constitutional</td><td>Anorexia</td><td colspan="2"/></tr><tr><td>Fatigue</td><td colspan="2"/></tr><tr><td>Fever</td><td colspan="2"/></tr><tr><td>Joint pains</td><td colspan="2"/></tr><tr><td>Myalgia</td><td colspan="2"/></tr><tr><td>Night sweats</td><td colspan="2"/></tr><tr><td>Weight gain</td><td colspan="2"/></tr><tr><td>Weight loss</td><td colspan="2"/></tr><tr><td>Neck pain</td><td colspan="2"/></tr></tbody></table><br/><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="15">Constitutional</td><td>GENERAL APPEARANCE:</td><td colspan="2">in no acute distress, well developed, well nourished</td></tr><tr><td>HEAD:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>EYES:</td><td colspan="2">pupils equal, round, reactive to light and accommodation</td></tr><tr><td>EARS:</td><td colspan="2">normal</td></tr><tr><td>THROAT:</td><td colspan="2">clear</td></tr><tr><td>NECK/THYROID:</td><td colspan="2">neck supple, full range of motion, no cervical lymphadenopathy</td></tr><tr><td>HEART:</td><td colspan="2">regular rate and rhythm,  S1, S2 normal,  no murmurs</td></tr><tr><td>CHEST</td><td colspan="2">clear to auscultation and percussion. Loop felt left chest wall</td></tr><tr><td>LUNGS:</td><td colspan="2">clear to auscultation bilaterally</td></tr><tr><td>ABDOMEN:</td><td colspan="2">normal, bowel sounds present, soft, nontender, nondistended</td></tr><tr><td>NEUROLOGIC:</td><td colspan="2">nonfocal, motor strength normal upper and lower extremities, sensory exam intact</td></tr><tr><td>SKIN:</td><td colspan="2">no suspicious lesions, warm and dry</td></tr><tr><td>EXTREMITIES:</td><td colspan="2">no clubbing, cyanosis, or edema</td></tr><tr><td>PSYCH:</td><td colspan="2">alert, oriented</td></tr><tr><td>ORAL CAVITY:</td><td colspan="2">mucosa moist</td></tr></tbody></table><br/></li></ul></div><br/><br/></body></html>